Refocus Eye Health of Central Connecticut, P.C.
Refocus Eye Health of Central Connecticut, P.C. was paid $8.21M by Medicaid between Feb 2021 and Dec 2024, across 43 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 57% of everything it billed.
33Billing provider infoREFOCUS EYE HEALTH OF CENTRAL CONNECTICUT, P.C.
WATERBURY, CT 06708
WATERBURY, CT 06708
33aNPI1548874936assigned 09/02/2020
33bProvider typeOptometrist
28Total paid$8.21M
24GClaims125,605
24DCodes billed43
24AFirst – last monthFeb 2021 – Dec 2024
Compared with peers
Next to other Optometrist providers in Connecticut
Rank by total paid#2 of 340
Median peer was paid$125K
This provider vs. median66×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 17,057 | $995K | |
| 2022 | 32,339 | $1.81M | |
| 2023 | 42,340 | $3.09M | |
| 2024incomplete | 33,869 | $2.32M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 57% | 7,786 | 4,354 | $4.72M |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 9.6% | 26,972 | 22,727 | $790K |
| 92015 | Determination of refractive state | 6.7% | 19,219 | 15,724 | $548K |
| 67028 | Intravitreal injection of a pharmacologic agent | 5.3% | 10,166 | 6,956 | $439K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 4.0% | 6,106 | 5,162 | $332K |
| 92134 | 2.4% | 16,919 | 14,056 | $201K | |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 2.2% | 259 | 167 | $180K |
| J0177 | Injection, aflibercept hd, 1 mg | 1.8% | 290 | 118 | $144K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.6% | 4,676 | 3,839 | $134K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 1.5% | 870 | 572 | $126K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.3% | 4,220 | 3,549 | $106K |
| 92083 | <1% | 3,445 | 2,924 | $78K |
31 more codes
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 3,815 | $67K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 4,334 | $65K |
| 92133 | <1% | 3,730 | $49K | |
| 92060 | <1% | 1,632 | $43K | |
| 99243 | <1% | 495 | $34K | |
| 92250 | <1% | 1,007 | $25K | |
| 92136 | <1% | 749 | $15K | |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 2,217 | $15K |
| V2020 | Frames, purchases | <1% | 497 | $14K |
| 92285 | <1% | 706 | $12K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 216 | $11K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 165 | $11K |
| 92202 | <1% | 2,107 | $10K | |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 321 | $7K |
| 92025 | <1% | 373 | $5K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 46 | $5K |
| 92235 | <1% | 147 | $5K | |
| S0580 | Polycarbonate lens (list this code in addition to the basic code for the lens) | <1% | 144 | $4K |
| 92020 | <1% | 371 | $3K | |
| 92201 | <1% | 316 | $3K | |
| V2203 | Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 63 | $3K |
| 92370 | <1% | 284 | $2K | |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 65 | $2K |
| 92341 | <1% | 72 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 49 | $2K |
| 76514 | <1% | 365 | $1K | |
| 68761 | <1% | 23 | $853.78 | |
| 11900 | <1% | 13 | $205.87 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 12 | $16.43 |
| 99024 | 0% | 246 | $0.00 | |
| 99058 | 0% | 97 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRINKOV, JEFF (CEO)
| Provider | Location | Paid |
|---|---|---|
| Refocus Eye Health of Connecticut PC | Bloomfield, CT | $517K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.